| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010480862 |
| P356 | DOI | 10.1007/S10620-012-2344-8 |
| P698 | PubMed publication ID | 22886595 |
| P2093 | author name string | György Baffy | |
| P2860 | cites work | Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter | Q24620189 |
| The implications of human metabolic network topology for disease comorbidity | Q24655183 | ||
| Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace | Q26858820 | ||
| Stress and the individual. Mechanisms leading to disease | Q28262768 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease | Q29417076 | ||
| Network medicine: a network-based approach to human disease | Q29547462 | ||
| Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease | Q29614897 | ||
| Nonalcoholic fatty liver disease | Q29619354 | ||
| Lipid homeostasis, lipotoxicity and the metabolic syndrome. | Q30383031 | ||
| Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers | Q33516543 | ||
| The role of antimicrobial peptides in animal defenses | Q33988529 | ||
| Bow ties, metabolism and disease | Q34343513 | ||
| Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma | Q34544988 | ||
| The general adaptation syndrome and the diseases of adaptation | Q34624806 | ||
| Biomarkers in the age of omics: time for a systems biology approach | Q34692190 | ||
| Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease | Q34812618 | ||
| Regulation of lipid droplets by autophagy | Q35056317 | ||
| Radical causes of cancer. | Q35097371 | ||
| Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems | Q35783139 | ||
| Human disease classification in the postgenomic era: a complex systems approach to human pathobiology | Q35940380 | ||
| Metabolic syndrome: a clinical and molecular perspective | Q36014668 | ||
| Uncoupling protein-2 and non-alcoholic fatty liver disease | Q36170167 | ||
| ??? | Q51425519 | ||
| Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents | Q36183590 | ||
| From acute ER stress to physiological roles of the Unfolded Protein Response | Q36362397 | ||
| From mice to men: insights into the insulin resistance syndromes | Q36387884 | ||
| Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice | Q36479005 | ||
| TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer | Q36777331 | ||
| Modulation of stress responses: how we cope with excess glucocorticoids | Q36880268 | ||
| Hepatic triglyceride synthesis and nonalcoholic fatty liver disease | Q37156321 | ||
| Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression | Q37280624 | ||
| Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects? | Q37666231 | ||
| Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective | Q37670371 | ||
| Socio-economic differentials in peripheral biology: cumulative allostatic load | Q37702387 | ||
| Body composition phenotypes in pathways to obesity and the metabolic syndrome | Q37820078 | ||
| Models and mechanisms of fibrosis resolution | Q37834043 | ||
| Genetics of alcoholic and nonalcoholic fatty liver disease | Q37871478 | ||
| Allostasis: a model of predictive regulation | Q37891463 | ||
| Maternal obesity, metabolic disease, and allostatic load. | Q37937099 | ||
| Systems biology and the future of medicine | Q38647215 | ||
| Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. | Q40070943 | ||
| Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. | Q42870876 | ||
| Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease | Q44934521 | ||
| Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. | Q45884813 | ||
| Price of adaptation--allostatic load and its health consequences. MacArthur studies of successful aging. | Q45988867 | ||
| Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients | Q70899118 | ||
| Cumulative biological risk and socio-economic differences in mortality: MacArthur studies of successful aging | Q79775113 | ||
| P433 | issue | 2 | |
| P921 | main subject | liver disease | Q929737 |
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| P304 | page(s) | 302-308 | |
| P577 | publication date | 2012-08-11 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Allostasis in nonalcoholic fatty liver disease: implications for risk assessment | |
| P478 | volume | 58 |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.